Our GHK-Cu protocols are designed for individuals looking to invest in long-term vitality
In individuals with primary coenzyme Q 10 deficiency, early treatment with high-dose coenzyme Q 10 supplementation (1030 mg/kg/day in children and 1.23.0 g/day in adults) may improve the pathological phenotype, yet the effectiveness depends on the type of mutations affecting the coenzyme Q 10 biosynthetic pathway (1, 26)
Dose titration is gradual over several months to minimise gastrointestinal side effects including nausea, vomiting, and diarrhoea
No added sugar (sweetened with sucralose), gluten free and lactose free
As obesity and diabetes continue to rise globally, Tirzepatide is being hailed not only for its glycemic benefits but also for its potential role in addressing metabolic health holistically
Innovators often file these later in the development cycle to extend protection